IN8BIO, INC. (INAB)
IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies
IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies
Navitas Collaborates with NVIDIA MGX™ Ecosystem to Accelerate 800 VDC AI Infrastructure
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
Virco Reports $2.8 Million First Quarter Loss as Demand for School Furniture Slows
KEYCORP TO PRESENT AT THE MORGAN STANLEY US FINANCIALS CONFERENCE
NRSInsights’ May 2026 Retail Same-Store Sales Report
Trust Stamp Bridges the Security Gap for Small and Mid-Sized Institutions; Partners with Ridgedale Federal Credit Union to Deliver Privacy-First Identity Orchestration
LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth
Odysight.ai to Participate in the 16th Annual ROTH London Conference on June 17 and 18
Neurocrine Biosciences to Present New Two‑Year CRENESSITY® (crinecerfont) Data on Key Clinical and Patient‑Reported Outcome Measures at ENDO 2026